TABLE 3.
Stage 1 |
Stage 2 |
|||
Nonedematous (n = 10) | Edematous (n = 9) | Nonedematous (n = 10) | Edematous (n = 9) | |
Dietary cysteine2 (μmol · kg−1 · h−1) | 7.8 ± 0.3 | 8.1 ± 0.2 | 19.8 ± 0.5 | 20.5 ± 0.4 |
Total intragastric cysteine 23 (μmol · kg−1 · h−1) | 10.9 ± 0.3 | 11.3 ± 0.2 | 22.8 ± 0.5 | 23.5 ± 0.4 |
Total exogenous cysteine 24 (μmol · kg−1 · h−1) | 13.9 ± 0.3 | 14.4 ± 0.3 | 25.8 ± 0.5 | 26.5 ± 0.4 |
Fraction of splanchnic uptake | 0.47 ± 0.04 | 0.51 ± 0.05 | 0.44 ± 0.03 | 0.43 ± 0.05 |
Splanchnic uptake 2 (μmol · kg−1 · h−1) | 5.10 ± 0.43 | 5.46 ± 0.75 | 10.02 ± 0.71 | 10.10 ± 1.22 |
All values are means ± SEMs. Stage 1: ∼4 d after admission; stage 2: ∼20 d after admission when the children were growing rapidly and had replaced 50% of their weight deficit. Values were compared by repeated-measures 2-factor ANOVA.
Main effect of stage, P < 0.01.
Sum of dietary cysteine and intragastric tracer cysteine.
Sum of dietary cysteine and intragastric and intravenous tracer cysteine.